Related Experiment Video
Updated: Feb 22, 2026

04:29
Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression
Published on: January 7, 2019
29.7K
Physician-Assisted Death and Severe, Treatment-Resistant Depression
The Hastings Center Report
|September 24, 2017
Summary
Physician-assisted death (PAD) is permitted for untreatable psychiatric conditions in Belgium and the Netherlands. This article questions why PAD, if justifiable, shouldn't extend to these patients when other treatments fail.
Area of Science:
- Medical Ethics
- Psychiatry
- End-of-Life Care
Background:
- Physician-assisted death (PAD) is legally permitted for psychiatric conditions in Belgium and the Netherlands under strict due care criteria.
- Opponents of PAD express concern that legalization may lead to the erosion of safeguards, such as terminal illness requirements.
- Supporters argue that limiting PAD to terminal or physical illnesses is arbitrary, as psychiatric suffering can be prolonged and untreatable.
Purpose of the Study:
- To explore the ethical considerations of physician-assisted death for individuals with untreatable psychiatric conditions.
- To examine the arguments for and against extending PAD eligibility beyond terminal physical illnesses.
- To question the rationale behind excluding psychiatric patients from PAD when other treatments are ineffective.
Main Methods:
- Ethical analysis of existing physician-assisted death legislation and practices in Belgium and the Netherlands.
- Review of arguments concerning the definition of suffering and treatability in psychiatric conditions.
- Philosophical inquiry into the justification of PAD based on patient autonomy and unbearable suffering.
Main Results:
- The current practice in Belgium and the Netherlands demonstrates that PAD for psychiatric conditions is possible, albeit rare.
- Arguments against PAD often focus on potential safeguards erosion, while proponents highlight the arbitrary nature of excluding psychiatric patients.
- The prolonged and potentially untreatable nature of suffering in severe psychiatric conditions presents a significant ethical challenge.
Conclusions:
- The ethical justification for PAD, if accepted, should logically extend to patients with untreatable psychiatric conditions.
- Excluding psychiatric patients from PAD may be considered discriminatory, particularly when their suffering is profound and persistent.
- Psychiatrists may face ethical dilemmas when patients with untreatable conditions request assistance in dying.
Related Concept Videos
Psychosis: Goals of Pharmacotherapy
636
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
636
Electroconvulsive Therapy
1.4K
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
1.4K
Antidepressant Drugs: MAOIs and Other Agents
1.0K
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
1.0K
Psychosurgery
2.0K
Psychosurgery, the surgical alteration or permanent removal of brain tissue to alleviate severe psychological conditions, stands as one of the most radical and controversial treatments in the history of mental health care. Its development and application have evolved significantly, marked by dramatic shifts in scientific understanding and ethical perspectives.
Historical Development of Psychosurgery
In the 1930s, Portuguese neurologist Antonio Egas Moniz introduced a surgical procedure designed...
Historical Development of Psychosurgery
In the 1930s, Portuguese neurologist Antonio Egas Moniz introduced a surgical procedure designed...
2.0K
Parkinson's Disease: Treatment
1.3K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.3K
Long-term Depression
33.4K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
33.4K

